Medical Billing Forum

Billing => Billing => : sls April 21, 2011, 12:02:39 PM

: using modifier 25
: sls April 21, 2011, 12:02:39 PM
i have a cardiologist who is doing a 99214, then doing an EKG.  We are a little confused on the modifier 25, i say if he uses a different diagnosis for the office visit we can use it.  Other billing states, it cant have the modifier 25 because he is a cardiologist and it is not a seperate service.  Any one doing this?  and can we bill it that way.  I thought rule of thumb was if you use a different diagnosis with a procedure modifier 25 can be used to include both. 
: Re: using modifier 25
: sequelian April 22, 2011, 03:18:32 AM
Modifier 25 will be use if u r using E&M code with anyother procedure for the same place of service regardless of dx codes...
: Re: using modifier 25
: Michele April 22, 2011, 10:47:42 AM
CPT Definition of modifier -25:  Significant, separately identifiable E&M service by the same physician on the same day of a procedure or other service: The physician may need to indicate that on the day a procedure or service identified by a CPT code was performed, the patient’s condition required a significant, separately identifiable E&M service above and beyond the other service provided or beyond the usual preoperative and postoperative care associated with the procedure that was performed. The E&M Service may be prompted by the symptom or condition for which the procedure was provided. As such, different diagnoses are not required for reporting the E&M services on the same date. The circumstance may be reported by adding modifier 25 to the appropriate level of E&M service. 

Actually, it isn't really based on diagnosis or place of service.  It is based on if the provider feels that the E&M visit meets the above guidelines of being significant, separately identifiable from the other procedure, in this case the EKG.  So if the E&M visit was strictly to perform and read the EKG it wouldn't warrant the 25 modifier, but if the provider covered other things, etc during the E&M then it would.

Hope that helps.
: Re: using modifier 25
: updastE October 25, 2022, 10:45:23 PM
<a href=https://stromectol.autos/>buy stromectol usa</a> 33, 34 Two of the largest series to date demonstrate 10 year prostate cancer specific survival rates of 65 to 73
: Re: using modifier 25
: ZooxySeno November 06, 2022, 10:12:45 PM
Isoniazid is a prodrug and must be activated by bacterial catalase <a href=https://nolvadex.one/>how to lose weight on tamoxifen</a>
: Re: using modifier 25
: mainiaDup November 13, 2022, 02:56:43 AM
6, 235, 883 on fully human monoclonal antibodies against human epidermal growth factor receptor; EP 184187 on a mouse human chimeric antibody; EP 844, 306 on a method of making antibodies recombinantly using phage technology; U <a href=https://priligy.me/>order priligy online</a>
: Re: using modifier 25
: unorgobug November 20, 2022, 04:31:05 AM
Many employers directly contribute cash incentives to these accounts <a href=http://doxycycline.world/>order doxycycline</a>
: Re: using modifier 25
: royagma November 20, 2022, 08:00:27 AM
<a href=http://lasix.autos/>lasix kidney function</a> Advantages of polymeric peracid over a homogeneous reagent are that the supported system is more stable making handling of toxic material easier can be recycled, and may be more selective
: Re: using modifier 25
: awaixebra December 09, 2022, 02:27:48 AM
89 for the ER positive patients included in PACS01 and BCIRG001 trials, respectively <a href=https://vlasixs.cyou>cheap lasix order</a> 877 OMNIPEN BIOCHEMIE 500 mg x 1 amp
: Re: using modifier 25
: piegmen December 12, 2022, 07:37:31 PM
<a href=http://nolvadex.lol>pct nolvadex dosage</a> Abdominal examination was inconclusive and vaginal examination not possible as she was a virgo intacta
: Re: using modifier 25
: lapound December 15, 2022, 10:05:02 AM
<a href=https://propecias.buzz>finasteride prescription</a> The three curves show the breast cancer risk in the population, the risk for the average carrier of an ATM mutation without taking family history into account, and the risk for a carrier of an ATM mutation whose mother also developed breast cancer at age 40
: Re: using modifier 25
: Vogegrorb December 16, 2022, 01:49:52 PM
J Cell Biochem 2002; 85 435 57 <a href=http://clomids.icu>buy clomiphene and gonadotropins</a>
: Re: using modifier 25
: uttessy January 31, 2023, 05:45:15 AM
candidate in human sexuality at Widener University, cofounder of sexpertise <a href=https://zithromax.buzz>zithromax side effects</a> In our study, interferons and ribavirin were coadminstered in 78
: Re: using modifier 25
: ideorrert February 03, 2023, 10:58:55 AM
<a href=http://cialis.christmas>cialis 20 mg</a> Doses between 25 and 250 mg per day are used with no adverse effects
: Re: using modifier 25
: Faispom February 04, 2023, 04:37:00 PM
Conclusions The observed frequency of zoster about 4 of patients after postoperative radiotherapy in this retrospective study suggests that the risk of developing zoster in this patient group may be 3 to 5 fold higher as compared to the incidence in the general population <a href=https://lasix.mom>what are the side effects of lasix</a> Lucky for us guys we are easier to figure out than women, since if we cannot get it up or there is no semen when we orgasm, then it is pretty apparent you have a health problem on your hands
: Re: using modifier 25
: knomype February 04, 2023, 08:06:32 PM
<a href=https://nolvadex.pics>buy tamoxifen</a> Benny LaSAUZEbImmKwCWXb 5 21 2022
: Re: using modifier 25
: Appoink March 08, 2023, 12:25:33 AM
<a href=https://buycialis.lol>buy cialis pills</a> For those with higher prescriptions, that prospect may vary The chances of us getting a 20 20 are about 20 or 30 percent, he says, but we have a very good chance of you functioning without glasses
: Re: using modifier 25
: Goormunny March 08, 2023, 04:51:00 AM
sulindac will increase the level or effect of chlorpropamide by acidic anionic drug competition for renal tubular clearance <a href=http://buycialis.buzz>generic cialis online europe</a>